As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  5/3/24  Aurinia Pharmaceuticals Inc.      ARS        12/31/23    1:25M                                                             
  5/3/24  Aurinia Pharmaceuticals Inc.      DEFA14A                1:434K                                                            
  5/3/24  Aurinia Pharmaceuticals Inc.      DEF 14A     6/14/24    8:4.5M                                                            
  5/2/24  Aurinia Pharmaceuticals Inc.      10-Q        3/31/24   87:5.6M                                                            
  5/2/24  Aurinia Pharmaceuticals Inc.      8-K:2,9      5/2/24   11:332K                                                            
 4/29/24  Aurinia Pharmaceuticals Inc.      10-K/A     12/31/23   12:1.3M                                                            
 3/20/24  ILJIN SNT Co., Ltd.               SC 13D/A               2:133K Aurinia Pharmaceuticals Inc.      Toppan Merrill/FA        
          Chin Kyu Huh³
          Iljin GLS Co., Ltd.³
          Iljin Semiconductor Co., Ltd.³
          Iljin Steel Co., Ltd.³
          Sae Kyoung Huh³
          Seoung Eun Huh³
  3/7/24  Greenleaf Peter                   4          Dir.,Off.²  1:5K   Aurinia Pharmaceuticals Inc.      Aurinia Pharmas Inc.     
  3/7/24  Miller Joseph M                   4          Officer²    1:5K   Aurinia Pharmaceuticals Inc.      Aurinia Pharmas Inc.     
  3/7/24  Donley Matthew Maxwell            4          Officer²    1:5K   Aurinia Pharmaceuticals Inc.      Aurinia Pharmas Inc.     
  3/7/24  Habig Scott Michael               4          Officer²    1:5K   Aurinia Pharmaceuticals Inc.      Aurinia Pharmas Inc.     
  3/7/24  Robertson Stephen P.              4          Officer²    1:5K   Aurinia Pharmaceuticals Inc.      Aurinia Pharmas Inc.     
 2/29/24  Knappertz Volker                  4          Officer²    1:4K   Aurinia Pharmaceuticals Inc.      Aurinia Pharmas Inc.     
 2/29/24  Aurinia Pharmaceuticals Inc.      8-K:5       2/27/24   10:145K                                                            
 2/22/24  Knappertz Volker                  4          Officer²    1:5K   Aurinia Pharmaceuticals Inc.      Aurinia Pharmas Inc.     
 2/22/24  Habig Scott Michael               4          Officer²    1:5K   Aurinia Pharmaceuticals Inc.      Aurinia Pharmas Inc.     
 2/22/24  Donley Matthew Maxwell            4          Officer²    1:5K   Aurinia Pharmaceuticals Inc.      Aurinia Pharmas Inc.     
 2/22/24  Robertson Stephen P.              4          Officer²    1:5K   Aurinia Pharmaceuticals Inc.      Aurinia Pharmas Inc.     
 2/22/24  Miller Joseph M                   4          Officer²    1:5K   Aurinia Pharmaceuticals Inc.      Aurinia Pharmas Inc.     
 2/22/24  Greenleaf Peter                   4          Dir.,Off.²  1:5K   Aurinia Pharmaceuticals Inc.      Aurinia Pharmas Inc.     

____________
¹	Filing/Form Types:
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	ARS	Annual Report to Security Holders.
	DEF 14A	Definitive Proxy Statement — Schedule 14A.
	DEFA14A	Definitive Additional Proxy Soliciting Material — Schedule 14A.
	SC 13D	Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.
³	Group Member:  A Registrant or non-Registrant party to this Filing made by a Group.